Julie K Freed1, Andreas M Beyer1, John A LoGiudice1, Joseph C Hockenberry1, David D Gutterman2. 1. From the Departments of Anesthesiology (J.K.F), Medicine-Cardiovascular Center (A.M.B., J.C.H., D.D.G.), and Plastic Surgery (J.A.L.), Medical College of Wisconsin, Milwaukee; and VA Medical Center, Milwaukee, WI (D.D.G.). 2. From the Departments of Anesthesiology (J.K.F), Medicine-Cardiovascular Center (A.M.B., J.C.H., D.D.G.), and Plastic Surgery (J.A.L.), Medical College of Wisconsin, Milwaukee; and VA Medical Center, Milwaukee, WI (D.D.G.). dgutt@mcw.edu.
Abstract
RATIONALE: Mitochondrial-derived hydrogen peroxide (H2O2) regulates flow-induced dilation (FID) in microvessels from patients with coronary artery disease. The relationship between ceramide, an independent risk factor for coronary artery disease and a known inducer of mitochondrial reactive oxygen species, and FID is unknown. OBJECTIVE: We examined the hypothesis that exogenous ceramide induces a switch in the mediator of FID from nitric oxide to H2O2. METHODS AND RESULTS: Internal diameter changes of resistance arterioles from human adipose and atrial tissue were measured by video microscopy. Mitochondrial H2O2 production was assayed in arterioles using mito peroxy yellow 1. Polyethylene glycol-catalase, rotenone, and Mito-TEMPO impaired FID in healthy adipose arterioles pretreated with ceramide, whereas N(ω)-nitro-l-arginine methyl ester had no effect. Mitochondrial H2O2 production was induced in response to flow in healthy adipose vessels pretreated with ceramide, and this was abolished in the presence of polyethylene glycol-catalase. Immunohistochemistry demonstrated ceramide accumulation in arterioles from both healthy patients and patients with coronary artery disease. N(ω)-nitro-l-arginine methyl ester reduced vasodilation to flow in adipose as well as atrial vessels from patients with coronary artery disease incubated with GW4869, a neutral sphingomyelinase inhibitor, whereas polyethylene glycol-catalase had no effect. CONCLUSIONS: Our data indicate that ceramide has an integral role in the transition of the mediator of FID from nitric oxide to mitochondrial-derived H2O2 and that inhibition of ceramide production can revert the mechanism of dilation back to nitric oxide. Ceramide may be an important target for preventing and treating vascular dysfunction associated with atherosclerosis.
RATIONALE: Mitochondrial-derived hydrogen peroxide (H2O2) regulates flow-induced dilation (FID) in microvessels from patients with coronary artery disease. The relationship between ceramide, an independent risk factor for coronary artery disease and a known inducer of mitochondrial reactive oxygen species, and FID is unknown. OBJECTIVE: We examined the hypothesis that exogenous ceramide induces a switch in the mediator of FID from nitric oxide to H2O2. METHODS AND RESULTS: Internal diameter changes of resistance arterioles from human adipose and atrial tissue were measured by video microscopy. Mitochondrial H2O2 production was assayed in arterioles using mito peroxy yellow 1. Polyethylene glycol-catalase, rotenone, and Mito-TEMPO impaired FID in healthy adipose arterioles pretreated with ceramide, whereas N(ω)-nitro-l-arginine methyl ester had no effect. Mitochondrial H2O2 production was induced in response to flow in healthy adipose vessels pretreated with ceramide, and this was abolished in the presence of polyethylene glycol-catalase. Immunohistochemistry demonstrated ceramide accumulation in arterioles from both healthy patients and patients with coronary artery disease. N(ω)-nitro-l-arginine methyl ester reduced vasodilation to flow in adipose as well as atrial vessels from patients with coronary artery disease incubated with GW4869, a neutral sphingomyelinase inhibitor, whereas polyethylene glycol-catalase had no effect. CONCLUSIONS: Our data indicate that ceramide has an integral role in the transition of the mediator of FID from nitric oxide to mitochondrial-derived H2O2 and that inhibition of ceramide production can revert the mechanism of dilation back to nitric oxide. Ceramide may be an important target for preventing and treating vascular dysfunction associated with atherosclerosis.
Authors: Hiroto Miura; John J Bosnjak; Gang Ning; Takashi Saito; Mamoru Miura; David D Gutterman Journal: Circ Res Date: 2003-02-07 Impact factor: 17.367
Authors: Yanping Liu; Hongtao Zhao; Hongwei Li; B Kalyanaraman; Alfred C Nicolosi; David D Gutterman Journal: Circ Res Date: 2003-08-14 Impact factor: 17.367
Authors: Thomas M Leurgans; Maria Bloksgaard; Jonathan R Brewer; Luis A Bagatolli; Maise H Fredgart; Kristoffer Rosenstand; Maria L Hansen; Lars M Rasmussen; Akhmadjon Irmukhamedov; Jo Gr De Mey Journal: Br J Pharmacol Date: 2016-04-06 Impact factor: 8.739
Authors: Andreas M Beyer; Matthew J Durand; Joseph Hockenberry; T Clark Gamblin; Shane A Phillips; David D Gutterman Journal: Am J Physiol Heart Circ Physiol Date: 2014-09-26 Impact factor: 4.733
Authors: Julie K Freed; Matthew J Durand; Brian R Hoffmann; John C Densmore; Andrew S Greene; David D Gutterman Journal: Am J Physiol Heart Circ Physiol Date: 2017-02-17 Impact factor: 4.733
Authors: Sergey Dikalov; Hana Itani; Bradley Richmond; Aurelia Vergeade; S M Jamshedur Rahman; Olivier Boutaud; Timothy Blackwell; Pierre P Massion; David G Harrison; Anna Dikalova Journal: Am J Physiol Heart Circ Physiol Date: 2019-01-04 Impact factor: 4.733